Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Ampio Pharmaceuticals Inc. (AMPE)

  • Technical Exchange News
  • April 15, 2024, 00:25 UTC
  • 33
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: . New value: Ampio Pharmaceuticals, Inc..

Comment Full text

Ampio Pharmaceuticals Inc. (AMPE)

  • Technical Exchange News
  • April 15, 2024, 00:25 UTC
  • 32
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: Ampio Pharmaceuticals, Inc.. New value: Ampio Pharmaceuticals, Inc..

Comment Full text

Ampio Pharmaceuticals Inc. (AMPE)

  • Technical Exchange News
  • April 15, 2024, 00:25 UTC
  • 33
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: Ampio Pharmaceuticals, Inc..

Comment Full text

Avadel Pharmaceuticals (AVDL)

  • Technical Exchange News
  • April 15, 2024, 00:24 UTC
  • 33
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share. New value: Avadel Pharmaceuticals plc - Ordinary Share.

Comment Full text

Xilio Therapeutics Inc. (XLO)

  • Technical Exchange News
  • April 13, 2024, 01:34 UTC
  • 33
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Sharecare Inc (SHCR)

  • Technical Exchange News
  • April 13, 2024, 01:34 UTC
  • 34
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Motus GI Holdings Inc. (MOTS)

  • Technical Exchange News
  • April 13, 2024, 01:34 UTC
  • 36
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

FSD Pharma Inc (HUGE)

  • Technical Exchange News
  • April 13, 2024, 01:34 UTC
  • 33
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Akari Therapeutics plc (AKTX)

  • Technical Exchange News
  • April 13, 2024, 01:33 UTC
  • 36
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Xilio Therapeutics Inc. (XLO)

  • Technical Exchange News
  • April 12, 2024, 18:49 UTC
  • 34
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text
  • Previous
  • 723
  • 724
  • 725
  • 726
  • 727
  • Next

Search

News categories

  • Technical Exchange News(11991)
  • Event(5170)
  • SEC News(248991)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(149670)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin